Semaglutide vs Ozempic: What's the Difference?
Semaglutide is the active molecule. Ozempic is one of three brand names that contain it (Ozempic, Wegovy, Rybelsus). Compounded semaglutide is a fourth source: same molecule, made by a US compounding pharmacy. Here is the full breakdown.
Last updated May 1, 2026.
Licensed providers · All 50 states · No insurance required
One-Line Answer
Semaglutide is the active drug. Ozempic is a brand name for it (specifically the formulation approved for type 2 diabetes). Wegovy is the brand name approved for weight management. Rybelsus is the brand name for oral semaglutide. All four contain semaglutide.
Side-by-Side
| Ozempic | Wegovy | Rybelsus | Compounded semaglutide | |
|---|---|---|---|---|
| Active molecule | Semaglutide | Semaglutide | Semaglutide | Semaglutide |
| Manufacturer | Novo Nordisk | Novo Nordisk | Novo Nordisk | US compounding pharmacy |
| Form | Weekly injection pen | Weekly injection pen | Daily oral tablet | Vial + syringe |
| FDA-approved indication | Type 2 diabetes | Weight management; CV risk | Type 2 diabetes | Per individual Rx |
| Max dose | 2.0 mg weekly | 2.4 mg weekly | 14 mg daily | Per Rx |
| Approx cash price | $950–1,050/mo | $1,300+/mo | $950/mo | $199–399/mo |
| Insurance coverage | T2D often | Expanding for obesity / CV | T2D often | Cash-pay primarily |
Why It Feels Confusing
Manufacturers brand the same molecule differently to match different indications and formulations. Ozempic was approved first (2017) for type 2 diabetes. Rybelsus came in 2019 as the oral version. Wegovy launched in 2021 for obesity at higher dosing. All three are Novo Nordisk products containing semaglutide. Compounded semaglutide entered telehealth offerings during periods of FDA shortage.
Are They Interchangeable?
The molecule is the same, but the products are formulated differently:
- Different maximum doses: Ozempic tops at 2.0 mg/week, Wegovy at 2.4 mg/week.
- Different routes: Ozempic and Wegovy are injections; Rybelsus is oral.
- Different indications: Insurance may cover one brand but not another.
A clinician may switch you between formulations based on indication, side effects, supply, and cost. Do not switch on your own.
Compounded vs Brand: Same Molecule, Different Oversight
Compounded semaglutide contains the same active ingredient but is made by a compounding pharmacy rather than Novo Nordisk. Differences include manufacturing oversight (FDA-approved manufacturing for brand vs state pharmacy oversight for compounded), packaging (pen vs vial), and inactive ingredients (preservatives, buffers, optional B12). Cost is significantly lower for compounded.
See compounded semaglutide for full detail.
Licensed providers · All 50 states · No insurance required
Cost Differences in Practice
- Ozempic: ~$950–1,050/month list; insurance often covers for T2D
- Wegovy: ~$1,300+/month list; insurance coverage expanding
- Rybelsus: ~$950/month list; insurance often covers for T2D
- Compounded: $199–399/month cash-pay through telehealth
Which Should You Get?
The decision depends on your indication and access:
- Type 2 diabetes: Ozempic or Rybelsus typically. Insurance more likely to cover.
- Weight management: Wegovy is the FDA-approved option among Novo Nordisk's products. Compounded semaglutide is the cash-pay alternative.
- Cost-sensitive: Compounded semaglutide for either indication, off-label for T2D when prescribed by a licensed clinician.
- Needle aversion: Rybelsus (oral), with the caveat that weight loss is smaller.
Frequently Asked Questions
Is semaglutide the same as Ozempic? +
Can I substitute semaglutide for Ozempic? +
Is compounded semaglutide the same as Ozempic? +
Related Reading
Sources
- FDA prescribing information for Ozempic, Wegovy, Rybelsus.